Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1

Table 1

Type of mutations, stages of disease (localized or metastatic), and setting of imatinib treatment (adjuvant or first line) of GIST patients.

Mutation analysis
Wild-type		13
Mutated	c-KIT	25
	PDGFRα	2
Onset
Localized		25
Metastatic		15
Imatinib, 400 mg
Mutated c-KIT	Adjuvant	8
	First line	10